An example of dyslipidemia in the form of a 4-ml sample of hyperlipidemic blood in a vacutainer with EDTA. Left to settle for four hours without centrifugation, the lipids separated into the top fraction.
Specialty
Cardiology
Symptoms
Atherosclerosis
Complications
Cardiovascular disease, coronary artery disease
Types
Hyperlipidemia, hypolipidemia
Dyslipidemia is a metabolic disorder characterized by abnormally high or low amounts of any or all lipids (e.g. fats, triglycerides, cholesterol, phospholipids) or lipoproteins in the blood.[1] Dyslipidemia is a risk factor for the development of atherosclerotic cardiovascular diseases (ASCVD),[1] which include coronary artery disease, cerebrovascular disease, and peripheral artery disease.[1] Although dyslipidemia is a risk factor for ASCVD, abnormal levels don't mean that lipid lowering agents need to be started.[2] Other factors, such as comorbid conditions and lifestyle in addition to dyslipidemia, is considered in a cardiovascular risk assessment.[3] In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood. This is often due to diet and lifestyle. Prolonged elevation of insulin resistance can also lead to dyslipidemia.[1] Likewise, increased levels of O-GlcNAc transferase (OGT) may cause dyslipidemia.[citation needed]
^ abcdDixon, Dave L; Riche, Daniel M (April 21, 2021). "Dyslipidemia". Pharmacotherapy:A Pathophysiological Approach, 11e. Book authored by Joseph T. DiPiro, Gary C. Yee, L. Michael Posey, Stuart T. Haines, Thomas D. Nolin, Vicki Ellingrod. Archived from the original on 2020-08-08.
^Rosenson, Robert S; Eckel, Robert H (April 9, 2021). "Hypertriglyceridemia". UpToDate. Retrieved April 21, 2021.
^Wilson, Peter WF (March 29, 2020). "Cardiovascular disease risk assessment for primary prevention in adults: Our approach". UpToDate. Retrieved April 22, 2021.
Dyslipidemia is a metabolic disorder characterized by abnormally high or low amounts of any or all lipids (e.g. fats, triglycerides, cholesterol, phospholipids)...
Lipaglyn) is a drug for the treatment of type 2 diabetes mellitus and dyslipidemia. It is approved for use in India by the Drug Controller General of India...
of dyslipidemia and the prevention of cardiovascular disease: Hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Fredrickson...
arrhythmia ECG of a 67-year-old man with sinus arrhythmia, hypertension, diabetes and dyslipidemia. Specialty Cardiology Diagnostic method electrocardiogram...
disorders that result in that finding. Hyperlipidemia represents a subset of dyslipidemia and a superset of hypercholesterolemia. Hyperlipidemia is usually chronic...
II clinical studies and other studies relating to obesity, diabetes, dyslipidemia and cardiovascular disease, but GSK abandoned further development of...
consumption of saturated fat is generally considered a risk factor for dyslipidemia, which in turn is a risk factor for some types of cardiovascular disease...
research based drug molecule Saroglitazar in the treatment of Diabetic Dyslipidemia under brand name "Lipaglyn". SoviHep is the first sofosbuvir brand launched...
Hypolipoproteinemia, hypolipidemia, or hypolipidaemia (British English) is a form of dyslipidemia that is defined by abnormally lowered levels of any or all lipids and/or...
that lignans have a positive effect on lipid profiles of patients with dyslipidemia related diseases. As of 2022 there is limited evidence that dietary intake...
that intermittent fasting may help with obesity, insulin resistance, dyslipidemia, hypertension, and inflammation. There is preliminary evidence that intermittent...
(2015-09-01). "Tinospora cordifolia stem supplementation in diabetic dyslipidemia: an open labelled randomized controlled trial". Functional Foods in Health...
Combined hyperlipidemia (or -aemia) is a commonly occurring form of hypercholesterolemia (elevated cholesterol levels) characterised by increased LDL and...
of these with schizophrenia may be partially due to medications (e.g. dyslipidemia from antipsychotics), environmental factors (e.g. complications from...
Chiarelli F, Bartuli A, Liccardo D, Ferrari F, et al. (2015). "Atherogenic dyslipidemia and cardiovascular risk factors in obese children". International Journal...
a thyromimetic drug that has been investigated for the treatment of dyslipidemia. A Phase III trial in humans was discontinued after the drug was found...
of cardiometabolic diseases including diabetes, insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD). Elafibranor is a dual...
diets, are associated with lower risk for vascular disease, obesity, dyslipidemia, hypertension, and type 2 diabetes. A third indicated that a vegan diet...
and are therefore hypolipidemic agents. Fibrates improve atherogenic dyslipidemia characterized by high triglyceride and/or low HDL-C levels and elevated...
but also because of increased risk factors (hypertension, diabetes, dyslipidemia, and obesity) and improved survival rates from other types of cardiovascular...
approved in the United States for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia), and/or triglycerides (hypertriglyceridemia)...
risk of several chronic diseases: the risk is moderate for obesity and dyslipidemia (more than 50%), and low for non-alcoholic fatty liver disease, type...
inflammatory disorders. Risk factors include cigarette smoking, advanced age, dyslipidemia, hypertension, and coronary artery disease. The pathophysiology of the...
effects may still possibly occur at the lower dosing ranges, such as dyslipidemia and neutropenia. These safety concerns at low doses are corroborated...
under the brand name Vascepa among others, is a medication used to treat dyslipidemia and hypertriglyceridemia. It is used in combination with changes in diet...
pressure, in particular if obese or during pregnancy Depression and anxiety Dyslipidemia – disorders of lipid metabolism – cholesterol and triglycerides. Women...
Global Information